Browse 37 archived publications.
2020-10-05
PharmaVentures advises Novartis on the sale of its manufacturing facility in Barberà del Vallès to Siegfried Holding AG
2020-03-26
PharmaVentures’ Industry Insight: We predict that licensing and partnering activity will remain steady in 2020
2018-09-06
PharmaVentures advises Vital Foods on the sale of its Zyactinase-based digestive health product asset portfolio to Mundipharma.
2018-08-20
PharmaVentures advises SalvaRx Group plc on the acquisition of SalvaRx Ltd by Portage Biotech Inc.
2018-04-11
PharmaVentures Strengthens Its First-Class Strategy Consulting & Dealmaking Capabilities
2018-03-19
Video Interview: NetScientific, Fighting chronic diseases on three fronts.
2017-12-15
PharmaVentures Capital Ltd advises Biosceptre International Ltd, a clinical stage oncology company, on its Series A private placement by Tuspark S&T
2016-10-28
PharmaVentures advises IDT Australia on the divestment of CMAX clinical trial business to the Japanese company I’rom Group Co. Ltd.
2016-07-27
PharmaVentures advises the Baylor Scott & White Research Institute on collaboration with Abzena plc and creation of Denceptor Therapeutics
2016-07-21
PharmaVentures expands corporate advisory services through new UK Financial Conduct Authority (FCA) regulated firm
2016-03-22
PharmaVentures advises 3Legs Resources on its acquisition of the Immuno-Oncology company SalvaRx who announced its admission for trading on AIM today
2016-02-04
PharmaVentures advises Transgene on the sale of their biopharmaceutical manufacturing facility
2015-12-17
PharmaVentures advises Stericool on sale to Sweden’s Getinge Group
2015-09-16
MDxHealth Acquires NovioGendix to Expand Uro-Oncology Product Offering
2015-09-04
PharmaVentures’ Latest Deal: Douglas Pharmaceuticals acquires Vital Foods’ Phloe product line in New Zealand
2015-06-30
PharmaVentures Completes M&A Deal for Technology in the Stem Cell and Regenerative Medicine Sector
2015-05-07
Are you Planning to Divest R&D or Manufacturing Facilities?
2015-05-05
PharmaVentures are Media Partners at the World Stem Cells & Regenerative Medicine Congress 2015
2015-03-04
PharmaVentures further strengthens its Business Development team
2015-02-11
PharmaVentures increases life science presence in the USA
2015-01-27
Client News Update: Novartis enters exclusive talks on the potential sale of its UK Horsham site to the University of Brighton
2015-01-02
Season’s Greetings from PharmaVentures 2014
2014-10-06
Convergence of Healthcare with ICT accelerates
2014-10-01
PharmaVentures Acts As Advisor to Plethora Solutions in deal with Recordati
2014-09-24
PharmaVentures increases its Asia-Pacific presence
2014-09-16
PharmaVentures Advises MedGenesis in Agreement with Pfizer for Its Potential Therapy for Parkinson’s Disease
2014-09-16
PharmaVentures strengthens its expertise in early stage deal making
2014-08-27
PharmaVentures acts as exclusive advisor on the sale of Medical Insight to Karos Health
2014-07-07
PharmaVentures Divests Manufacturing Facility for Major Pharma Client
2014-05-16
PharmaVentures expands reach to Latin America
2014-05-09
PharmaVentures engaged in valuation of assets for newly AIM listed Tiziana Life Sciences.
2014-04-11
Novartis appoints PharmaVentures as advisors on the future of its UK Horsham site
2014-04-02
Pharma is attracted to early-stage antibody deals in Oncology
2013-12-18
Season’s Greetings from PharmaVentures
2013-12-11
PharmaVentures Strengthens M&A Team
2013-10-23
PharmaVentures advised Nanosight on its sale to Spectris plc.
2013-10-23